ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,799 | -28.4% | 2,404 | -2.1% | 0.00% | – |
Q2 2023 | $5,303 | +10.6% | 2,455 | +7.5% | 0.00% | – |
Q1 2023 | $4,796 | – | 2,284 | +3072.2% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 72 | -99.6% | 0.00% | – |
Q4 2021 | $153,000 | +3725.0% | 20,465 | +1461.0% | 0.00% | – |
Q3 2020 | $4,000 | -76.5% | 1,311 | -65.0% | 0.00% | – |
Q2 2020 | $17,000 | – | 3,744 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |